Background: This article summarizes the European Renal Association -European Dialysis and Transplant Association (ERA-EDTA) Registry's 2015 Annual Report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2015 within 36 countries.
Introduction
The European Renal Association -European Dialysis and Transplant Association (ERA-EDTA) Registry's Annual Report describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) within Europe and countries bordering the Mediterranean Sea based on data collected via national and regional renal registries [1] . On an annual basis we publish a summary of the ERA-EDTA Registry's Annual Report that is intended to provide an overview of the current status of RRT for ESRD in Europe [2] [3] [4] . In 2016 and 2017, we received the 2015 data from 52 national or regional renal registries in 36 countries covering a general population of 683.4 million people, representing 80.3% of the 2015 European general population. Thirty-two national or regional renal registries from 17 countries provided individual patient data, whereas 20 countries or Table 1 . Incidence of RRT in 2015 at Day 1, for all primary renal diseases combined and diabetes mellitus Types 1 and 2, as count (n) and unadjusted rate pmp, and the mean age at the start of RRT shown as dark bars, and registries providing aggregated-level data as light bars. Adjustment of incidence rates was performed by standardizing the rates to the age and gender distribution of the EU27 population [5] . The incidence rate for Bulgaria, the Czech Republic, Russia and Slovakia only includes patients receiving dialysis.
For England (UK), the overall incidence of RRT is underestimated by 4%. This summary presents the 2015 incidence and prevalence of patients receiving RRT, kidney transplantation activity and the patient and graft survival in these 36 countries. A description of the methods to analyse the data, along with the full results, can be found in the ERA-EDTA Registry 2015 Annual Report [1] .
Results

Incidence of RRT
In 2015, 81 373 individuals commenced RRT for ESRD, which equated to an overall unadjusted incidence rate of 119 per million population (pmp, Table 1 ). The unadjusted incidence rate was highest in the Czech Republic (232 pmp), Greece (227 pmp) and Portugal (227 pmp), whereas it was lowest in Ukraine (24 pmp) and Russia (51 pmp, Table 1 and Figures 1 and 2 ). The top five countries with the highest incident rates were equal to the top five in 2014, except for the Czech Republic, which had the fourth highest incident rate in 2014, but the highest incident rate in 2015. Of the patients commencing RRT, 62% were men, 52% were aged 65 years and 23% had diabetes mellitus as their primary renal diagnosis ( Figure 3 ). The mean age of the patients commencing RRT in all countries and regions combined was 63.1 years, ranging from 48.1 years in Albania to 70.6 years in the Dutch-speaking part of Belgium (Table 1) . The majority of patients started RRT with haemodialysis (85%), while 11% of patients started with peritoneal dialysis and 4% received a preemptive kidney transplant ( Figure 4 ). However, the initial treatment modality varied considerably between age groups, as the proportion of patients receiving either peritoneal dialysis or a pre-emptive transplant decreased with increasing age. Furthermore, patients with a primary renal diagnosis of diabetes mellitus were less likely to receive a pre-emptive kidney transplant compared with the non-diabetic group (2% versus 6%). Of the incident patients alive and receiving RRT at Day 91 after the start of treatment, the majority (82%) were receiving haemodialysis, 13% were receiving peritoneal dialysis and 5% were living with a kidney transplant ( Figure 5 ). In the first 90 days of treatment, the percentage of patients receiving haemodialysis decreased, this was particularly evident in the younger age groups.
Prevalence of RRT
On 31 December 2015, 546 783 individuals were receiving RRT for ESRD (Table 2) . This corresponds to an overall unadjusted prevalence of 801 pmp. Again there was considerable variation between countries, with the highest unadjusted prevalence seen in Portugal (1824 pmp) and the Spanish regions of Catalonia (1355 pmp) and Valencia (1333 pmp) ( Table 2 and Figures 6 and 7) . The unadjusted prevalence of RRT was considerably lower in Ukraine (178 pmp) and Russia (303 pmp). The top five countries with the highest prevalence remained the same as with 2014. Of the prevalent patients the majority were men (60%), 42% were aged 65 years and 16% had diabetes mellitus as their primary renal diagnosis (Figure 8 ). The mean age of the prevalent patients receiving RRT in all countries and regions combined was 60.8 years, ranging from 48.6 years in Ukraine to 66.8 years in Portugal ( Table 2 ). The majority of prevalent patients (58%) were receiving haemodialysis, 36% of patients were living with a kidney transplant and only 5% were on peritoneal dialysis (Figure 9 ). Once again the modality of RRT varied considerably between age groups as the proportion of patients with a kidney transplant decreased with increasing age. For those aged 20-44 years, 66% were living with a kidney transplant whereas this was true for only 42% of patients aged 65-74 years. Prevalent patients with a primary renal diagnosis of diabetes mellitus were much less likely to be living with a kidney transplant compared with the patients without diabetes mellitus (28% versus 49%).
Kidney transplantation
In 2015, 21 056 kidney transplantations were performed, which equated to an overall unadjusted transplant rate of 31 pmp (Figure 10 ). Again there was considerable variation between countries/regions with unadjusted kidney transplant rates well over 70 pmp in some Spanish regions, and very low unadjusted kidney transplant rates in Ukraine (2 pmp) and Macedonia (6 pmp). Overall, the unadjusted deceased donor transplant rate was more than twice that of the unadjusted living donor transplant rate (23 pmp versus 10 pmp; 68% versus 29%, Figure 11) . The highest unadjusted rates of deceased donor transplants were seen in some Spanish regions (>60 pmp, Figure 12 ), whereas the highest unadjusted rate of living donor transplants were seen in the Netherlands (30 pmp), Turkey (32 pmp) and Northern Ireland (33 pmp, Figure 12 ).
Survival of patients receiving RRT
For patients commencing RRT in the period 2006-10, the 1-, 2-and 5-year unadjusted patient survival probabilities for all RRT modalities combined were 83.2% [95% confidence interval (CI) 83.1-83.4], 72.7% (95% CI 72.6-72.9) and 50.0% (95% CI 49.9-50.1), respectively (see Table 3 for a description of the countries/ regions included in this analysis). For patients commencing dialysis between 2006 and 2010, the 5-year unadjusted patient survival probability was 41.8% (95% CI 41.7-41.9). Adjusted The prevalence is underestimated by 3% due to an estimated 30% underreporting of patients living on a functioning graft. e The prevalence is underestimated by 6% due to an estimated 11% underreporting of patients living on a functioning graft. f Data on the prevalence of primary renal disease (DM) is based on 6400 dialysis patients (8.7% of total).
g The prevalence is underestimated by 1% due to a small number of centres not submitting complete data for 2015.
DM, diabetes mellitus as primary renal disease.
analyses comparing patient survival on haemodialysis and peritoneal dialysis revealed higher survival probabilities in the first 3 years for patients on peritoneal dialysis (Figure 13 See Table 3 for a description of the adjustments made and the countries/regions included in this analysis.
Expected remaining lifetime
There remains a substantial difference in the expected remaining lifetime between the general population and those receiving dialysis (Figure 14) . Patients aged 20-44 years receiving dialysis are expected to live only one-third of the estimated remaining lifetime of the age-matched general population, which is about 35 years less. The prospect is even worse for patients aged 55-64 years, as they are expected to live only a quarter as long as their age-matched counterparts in the general population (20 years less). Patients living with a kidney transplant fare better than those receiving dialysis. are shown as dark bars, and registries providing aggregated-level data as light bars. Adjustment of the prevalence was performed by standardizing the prevalence to the age and gender distribution of the EU27 population [5] . The prevalence for Israel, Slovakia and Tunisia (Sfax region) only includes patients receiving dialysis. For Romania, Switzerland and England (UK), the overall prevalence of RRT is underestimated by, respectively, 3, 6 and 1%.
However, the life expectancy of the transplant recipients aged 20-44 years is still approximately one-third less than that of the agematched general population (17 years less). With increasing age of transplant recipients the percentage disparity in life expectancy with the age-matched general population also increases. Wales. The total count for Austria is based on residents and non-residents. For Romania, Switzerland and England (UK), the overall transplant rate is underestimated by, respectively, 30, 6 and 7%. 4 (93.9-94.9) This is based on data from the following renal registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Denmark, Analyses were adjusted using fixed values: age (50 years), gender (63% men) and primary renal disease (14% diabetes mellitus, 10% hypertension/renal vascular disease, 23% glomerulonephritis and 53% other causes). 
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